{"hands_on_practices": [{"introduction": "Effective differential diagnosis in parasitology begins with mastering the foundational, hands-on techniques of microscopy. This first practice challenges you to construct a systematic laboratory protocol for distinguishing pathogenic and non-pathogenic amoebae from a host of common artifacts like plant cells, yeasts, and human macrophages [@problem_id:4803319]. By evaluating and selecting the best diagnostic workflow, you will build the core observational skills and procedural knowledge that are the bedrock of accurate morphological identification.", "problem": "A clinical parasitology laboratory receives a fresh, unpreserved diarrheal stool specimen from a patient with abdominal pain. The laboratory is tasked with ruling out pathogenic amoebiasis and preventing misidentification of artifacts. You must construct a protocol-specific checklist that, within a routine wet-mount plus permanent-stain workflow, minimizes mistaking plant cells, yeasts, and intestinal macrophages for Entamoeba trophozoites and permits differential consideration of Entamoeba histolytica (E. histolytica), Entamoeba dispar (E. dispar), and Entamoeba coli (E. coli; amoeba, not the bacterium). Base your reasoning on core definitions and well-tested observations about protozoan motility, light microscopy, and staining, without assuming any specialized molecular tests.\n\nWhich option best specifies such a checklist and justifies each distinguishing feature?\n\nA. \n- First, examine a fresh saline wet mount within $30$ minutes at room temperature to assess motility. True amoeboid motility is directional and progressive with a single, hyaline pseudopodium in E. histolytica/E. dispar and is sluggish with multiple blunt pseudopodia in E. coli; plant cells, yeasts, and macrophages do not exhibit true amoeboid motility.\n- Measure size with a calibrated ocular micrometer: E. histolytica/E. dispar trophozoites are typically $12$–$60\\,\\mu\\mathrm{m}$, E. coli $15$–$50\\,\\mu\\mathrm{m}$; yeasts are commonly $3$–$10\\,\\mu\\mathrm{m}$ single cells; plant elements can be larger with angular contours; macrophages often $20$–$40\\,\\mu\\mathrm{m}$. Use size as supportive, not decisive.\n- After motility assessment, switch to iodine wet mount to visualize nuclear detail and glycogen; note iodine halts motility. Identify a small central karyosome with fine, evenly distributed peripheral chromatin in E. histolytica/E. dispar; identify an eccentric karyosome with coarse, irregular peripheral chromatin in E. coli. Artifacts lack this nuclear architecture: plant cells have rigid cellulose walls and may show iodine-positive starch granules without a protozoan nucleus; yeasts show budding forms and refractile vacuoles without a karyosome/peripheral chromatin pattern; macrophages have a single large nucleus with lacy chromatin, not a discrete karyosome or peripheral chromatin ring.\n- Prepare a trichrome-stained permanent smear to confirm nuclear chromatin patterns and cytoplasmic inclusions. Ingestion of red blood cells (RBCs) supports E. histolytica; absence of erythrophagocytosis supports E. dispar. E. coli trophozoites often contain bacteria and debris. Yeasts retain budding morphology; plant cells retain rigid walls; macrophages show vacuolated cytoplasm and phagolysosomal granules.\n- If plant material is suspected, use polarized light to detect birefringent cellulose and corroborate angular cell walls or chloroplast remnants; true trophozoites lack birefringent walls.\n- Document which features are decisive (e.g., erythrophagocytosis) versus supportive (e.g., size), and avoid relying on any single feature in isolation.\n\nB.\n- Begin with iodine wet mount to enhance motility, evaluating pseudopodia after $15$ minutes.\n- Diagnose E. dispar trophozoites by the presence of ingested RBCs; diagnose E. coli trophozoites by a central karyosome with fine peripheral chromatin.\n- Classify budding yeasts as protozoa because budding indicates active locomotion and pseudohyphae mimic pseudopodia.\n- Exclude plant cells because they lack a cell wall by light microscopy; identify macrophages by multiple nuclei arranged peripherally, mimicking amoebic cysts.\n\nC.\n- Examine a fresh wet mount for motility before adding iodine, and measure size; use iodine second because it halts motility.\n- Use a trichrome-stained permanent smear to confirm nuclear features and cytoplasmic inclusions; the absence of ingested RBCs in trophozoites conclusively identifies E. dispar over E. histolytica; an eccentric karyosome with coarse peripheral chromatin suggests E. coli.\n- Distinguish yeasts by budding and pseudohyphae; distinguish plant cells by rigid angular outlines and a rigid cell wall; distinguish macrophages by a single large nucleus with lacy chromatin and abundant vacuoles; artifacts lack amoeboid motility. Macrophages are typically smaller than amoebae, usually $<10\\,\\mu\\mathrm{m}$.\n- Optionally use polarized light to detect birefringence in plant materials.\n\nD.\n- Use Gram staining exclusively: Gram-negative staining identifies Entamoeba species; Gram-positive staining indicates yeasts and plant cells.\n- Assess motility and the presence of cilia on a fixed trichrome smear under oil immersion; amoebae lack visible nuclei by light microscopy.\n- Identify E. coli cysts by $2$ nuclei and E. histolytica/E. dispar cysts by $8$ nuclei.\n- Chlorinate the stool to lyse plant cells while preserving amoebae for improved specificity.\n\nSelect the single best option.", "solution": "The user has provided a problem that requires the construction of a diagnostic checklist for identifying intestinal amoebae and differentiating them from common artifacts in a stool sample. The analysis must be based on standard light microscopy techniques without resource to molecular methods.\n\n### Step 1: Extract Givens\n-   **Specimen Type**: Fresh, unpreserved diarrheal stool.\n-   **Patient Symptoms**: Abdominal pain.\n-   **Primary Objective**: Rule out pathogenic amoebiasis (caused by *Entamoeba histolytica*).\n-   **Methodology**: Routine wet-mount plus permanent-stain workflow.\n-   **Organisms for Differential Diagnosis**: *Entamoeba histolytica* (*E. histolytica*), *Entamoeba dispar* (*E. dispar*), *Entamoeba coli*.\n-   **Artifacts for Differentiation**: Plant cells, yeasts, intestinal macrophages.\n-   **Target Life Cycle Stage**: Trophozoites.\n-   **Constraints**: Reasoning must be based on motility, light microscopy, and staining. No specialized molecular tests are to be assumed.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem is well-grounded in the established principles of clinical medical parasitology. The differentiation of *E. histolytica*, *E. dispar*, and *E. coli*, along with common artifacts like macrophages, yeast, and plant cells, is a fundamental and classic challenge in the diagnostic laboratory. The methods described (wet mount, permanent stain) are standard procedures. The biological characteristics used for differentiation (motility, nuclear structure, cytoplasmic inclusions) are factually correct and form the basis of morphological diagnosis.\n-   **Well-Posed**: The problem asks for the \"best\" checklist among the given options. This is a well-posed question that requires evaluating the accuracy, completeness, and logical flow of several proposed diagnostic protocols. A unique best answer can be determined by comparing the options against established best practices in parasitology.\n-   **Objective**: The problem is stated in objective, technical language devoid of subjectivity or bias. All terms used have precise meanings within the field.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. It is a scientifically sound, well-posed, and objective question rooted in standard laboratory practice. I will proceed with a full analysis of the options.\n\n### Analysis of the Problem and Derivation of Correct Protocol\nA correct protocol for differentiating *Entamoeba* trophozoites from each other and from artifacts in a fresh diarrheal specimen must follow a logical sequence that maximizes the information gathered from each step.\n\n1.  **Initial Examination (Saline Wet Mount)**: Given a fresh, unpreserved sample, the first priority is to observe motility. This must be done quickly, ideally within $30$-$60$ minutes of specimen passage, as trophozoites are fragile and lose motility as they cool and degrade. A saline wet mount is used.\n    -   *E. histolytica*/*E. dispar* typically exhibit active, progressive, and directional motility via the explosive extension of a single, clear (hyaline) pseudopod.\n    -   *E. coli* exhibits sluggish, non-progressive motility with multiple, blunt, granular pseudopodia.\n    -   Artifacts (yeast, plant cells) are non-motile. Macrophages may show some amoeboid movement but it is not the characteristic, rapid, purposeful movement of *E. histolytica*.\n\n2.  **Stained Wet Mount (Iodine)**: After assessing motility, an iodine wet mount is prepared from the same sample. Iodine kills the organisms, halting motility, but stains internal structures, particularly the nucleus and glycogen vacuoles, making them more visible than in saline. This step provides preliminary information on nuclear morphology.\n    -   *E. histolytica*/*E. dispar* nucleus: Appears as a delicate ring with a small, central dot (karyosome). The peripheral chromatin is fine and evenly distributed.\n    -   *E. coli* nucleus: More prominent, with a larger, often eccentric karyosome and coarse, irregular peripheral chromatin.\n\n3.  **Permanent Stained Smear (e.g., Trichrome)**: This is the definitive step for morphological identification. The permanent stain provides the highest resolution for observing detailed nuclear and cytoplasmic features.\n    -   **Nuclear Confirmation**: The nuclear features seen in the iodine mount are confirmed with greater clarity.\n    -   **Cytoplasmic Inclusions**: This is critical for species-level differentiation. The presence of ingested red blood cells (erythrophagocytosis) in the cytoplasm is pathognomonic for *E. histolytica* and distinguishes it from the non-invasive *E. dispar*. The cytoplasm of *E. coli* is often described as \"dirty\" or vacuolated, containing ingested bacteria, yeast, and debris, but not typically RBCs.\n    -   **Artifact Differentiation**:\n        -   **Macrophages**: Have a single, often indented or lobed nucleus that is much larger in proportion to the cell size compared to *Entamoeba*. The chromatin is 'lacy' or net-like, and there is no distinct peripheral chromatin ring or central karyosome.\n        -   **Yeasts**: Are typically smaller ($3$–$10\\,\\mu\\mathrm{m}$), may show budding, and lack an amoebic nucleus.\n        -   **Plant cells**: Have rigid, often angular cell walls. They lack amoebic motility and nuclear structure. The cellulose wall can be confirmed using polarized light, where it will appear birefringent.\n\n4.  **Size Measurement**: An ocular micrometer is used throughout the process. While there is considerable size overlap, it serves as a supportive characteristic. *E. histolytica*/*E. dispar* trophozoites are typically $12$–$60\\,\\mu\\mathrm{m}$ (invasive forms are often larger, $>20\\,\\mu\\mathrm{m}$), while *E. coli* are $15$–$50\\,\\mu\\mathrm{m}$. Macrophages are often $20$–$40\\,\\mu\\mathrm{m}$. Yeasts are much smaller.\n\nA robust checklist would incorporate all these points in the correct logical order and use precise, scientifically accurate descriptions.\n\n### Option-by-Option Analysis\n\n**A. First, examine a fresh saline wet mount within $30$ minutes...**\n-   The step-by-step procedure is logically sound: $1$. Saline wet mount for motility. $2$. Size measurement. $3$. Iodine wet mount for preliminary nuclear detail. $4$. Trichrome stain for confirmation and key differentiators. $5$. Ancillary test (polarized light) for specific artifacts.\n-   The descriptions provided for each step are factually correct. Motility of *E. histolytica/E. dispar* vs. *E. coli* is described accurately. The size ranges are standard. The nuclear characteristics (karyosome, peripheral chromatin) for each species are correct. The key role of erythrophagocytosis for identifying *E. histolytica* is correctly stated. The descriptions of artifacts (plant cells, yeasts, macrophages) and how to differentiate them are accurate and detailed.\n-   The concluding statement about using a combination of features and distinguishing \"decisive\" vs. \"supportive\" evidence reflects excellent diagnostic practice.\n-   **Verdict: Correct.** This option provides a comprehensive, accurate, and methodologically sound protocol.\n\n**B. Begin with iodine wet mount to enhance motility...**\n-   This option contains multiple fundamental errors.\n-   \"Begin with iodine wet mount to enhance motility\" is incorrect. Iodine is a fixative that **halts** motility.\n-   \"Diagnose E. dispar trophozoites by the presence of ingested RBCs\" is incorrect. Ingested RBCs are characteristic of **E. histolytica**.\n-   \"diagnose E. coli trophozoites by a central karyosome with fine peripheral chromatin\" is incorrect. This nuclear morphology describes **E. histolytica/E. dispar**, not *E. coli*.\n-   \"Classify budding yeasts as protozoa\" is incorrect. Yeasts are fungi. \"budding indicates active locomotion\" is incorrect; budding is a form of asexual reproduction.\n-   \"Exclude plant cells because they lack a cell wall\" is incorrect. Plant cells possess a distinct, rigid cell wall.\n-   \"identify macrophages by multiple nuclei\" is incorrect. Macrophages are typically uninucleate.\n-   **Verdict: Incorrect.** This option is factually wrong on nearly every point.\n\n**C. Examine a fresh wet mount for motility before adding iodine...**\n-   The initial steps are described correctly (\"Examine a fresh wet mount for motility before adding iodine... use a trichrome-stained permanent smear... an eccentric karyosome with coarse peripheral chromatin suggests E. coli.\").\n-   However, it contains a critical flaw: \"macrophages are typically smaller than amoebae, usually $<10\\,\\mu\\mathrm{m}$.\" This is factually incorrect. Macrophages typically measure $20$–$40\\,\\mu\\mathrm{m}$, a size range that significantly overlaps with *Entamoeba* trophozoites, which is why they are a common source of confusion. A size of $<10\\,\\mu\\mathrm{m}$ is more typical of a lymphocyte. This error in a key differential point makes the checklist unreliable.\n-   The statement \"absence of ingested RBCs... conclusively identifies E. dispar\" is an overstatement. While absence is highly suggestive, the term \"conclusively\" is too strong in morphology-based diagnosis, as a non-invasive *E. histolytica* may not have ingested RBCs. Option A uses the more cautious and appropriate term \"supports.\"\n-   **Verdict: Incorrect.** Due to the significant factual error regarding macrophage size and the less precise diagnostic language, this option is inferior to A.\n\n**D. Use Gram staining exclusively...**\n-   This option is entirely incorrect.\n-   \"Use Gram staining exclusively\" is wrong. Gram stain is for bacteria; the standard for protozoa is a permanent stain like trichrome or iron hematoxylin.\n-   \"Assess motility ... on a fixed trichrome smear\" is impossible; fixation immobilizes organisms.\n-   \"amoebae lack visible nuclei by light microscopy\" is patently false; nuclear morphology is a cornerstone of their identification.\n-   \"Identify E. coli cysts by $2$ nuclei and E. histolytica/E. dispar cysts by $8$ nuclei\" is the reverse of the truth. Mature *E. histolytica/E. dispar* cysts have up to $4$ nuclei; mature *E. coli* cysts have up to $8$.\n-   \"Chlorinate the stool\" is not a standard parasitological procedure and would destroy the amoebae.\n-   **Verdict: Incorrect.** This option demonstrates a complete lack of understanding of basic parasitology and laboratory methods.\n\n### Conclusion\nOption A provides the only accurate, comprehensive, and logically sequenced checklist that aligns with established best practices in diagnostic parasitology. It correctly identifies the purpose of each test, accurately describes the key morphological features of each organism and artifact, and emphasizes a sound, evidence-based diagnostic approach.", "answer": "$$\\boxed{A}$$", "id": "4803319"}, {"introduction": "Once you have a grasp of the qualitative features used in identification, the next step is to understand the quantitative limitations of your diagnostic methods. This exercise simulates a realistic public health scenario where the non-pathogenic amoeba *Entamoeba dispar* is far more common than the pathogenic *Entamoeba histolytica* [@problem_id:4803304]. You will use principles of conditional probability to calculate the false positive rate, $P(T^{+} \\mid H^{-})$, demonstrating how the high prevalence of mimics can significantly impact the reliability of a purely morphology-based diagnosis.", "problem": "A clinical microbiology laboratory in a region with high prevalence of *Entamoeba dispar* relies solely on light microscopy for reporting *Entamoeba histolytica* in stool specimens, without Enzyme-Linked Immunosorbent Assay (ELISA) antigen detection or Polymerase Chain Reaction (PCR) confirmation. Microscopy is known to yield indistinguishable cyst morphology for *Entamoeba histolytica* and *Entamoeba dispar*, and to occasionally misclassify *Entamoeba coli* as *Entamoeba histolytica*.\n\nAssume a cross-sectional sample of the local population with the following true prevalences: *Entamoeba histolytica* with prevalence $P(H) = 0.02$, *Entamoeba dispar* with prevalence $P(D) = 0.25$, *Entamoeba coli* with prevalence $P(C) = 0.12$, and no infection by these three amoebae with prevalence $P(N) = 0.61$. The laboratory reports “*Entamoeba histolytica* detected” by morphology when:\n- True *Entamoeba dispar* is present with probability $P(T^{+} \\mid D) = 0.85$,\n- True *Entamoeba coli* is present with probability $P(T^{+} \\mid C) = 0.07$,\n- None of the three is present with probability $P(T^{+} \\mid N) = 0.01$.\n\nHere, $T^{+}$ denotes a positive morphological call of “*Entamoeba histolytica*.” The false positive rate for *Entamoeba histolytica* is defined as $P(T^{+} \\mid H^{-})$, where $H^{-}$ means *Entamoeba histolytica* is truly absent.\n\nStarting from fundamental definitions of conditional probability and the law of total probability, derive an expression for $P(T^{+} \\mid H^{-})$ in terms of the given quantities, evaluate it numerically, and present the final result rounded to four significant figures. Express your answer as a decimal without a percentage sign.", "solution": "The problem requires the calculation of the false positive rate for *Entamoeba histolytica*, which is formally defined as the conditional probability $P(T^{+} \\mid H^{-})$. Here, $T^{+}$ denotes a positive test result (a morphological report of “*Entamoeba histolytica* detected”), and $H^{-}$ denotes the event that a person is truly not infected with *E. histolytica*.\n\nFirst, we must define the sample space. The problem provides prevalences for four mutually exclusive and exhaustive states of infection:\n$1$. The event $H$ is a true infection with *Entamoeba histolytica*, with prevalence $P(H) = 0.02$.\n$2$. The event $D$ is a true infection with *Entamoeba dispar*, with prevalence $P(D) = 0.25$.\n$3$. The event $C$ is a true infection with *Entamoeba coli*, with prevalence $P(C) = 0.12$.\n$4$. The event $N$ is no infection with any of the three amoebae, with prevalence $P(N) = 0.61$.\n\nThe total probability is $P(H) + P(D) + P(C) + P(N) = 0.02 + 0.25 + 0.12 + 0.61 = 1.00$, which confirms that these events form a partition of the sample space.\n\nThe event $H^{-}$ signifies that a person is not infected with *E. histolytica*. Given the partition, this event is the union of the other three states:\n$$H^{-} = D \\cup C \\cup N$$\nThe probability of $H^{-}$, denoted $P(H^{-})$, can be calculated in two ways. First, as the complement of $H$:\n$$P(H^{-}) = 1 - P(H) = 1 - 0.02 = 0.98$$\nAlternatively, since $D$, $C$, and $N$ are mutually exclusive events:\n$$P(H^{-}) = P(D) + P(C) + P(N) = 0.25 + 0.12 + 0.61 = 0.98$$\nBoth methods yield the same result, confirming the consistency of the provided data.\n\nThe quantity to be determined is the false positive rate, $P(T^{+} \\mid H^{-})$. By the fundamental definition of conditional probability:\n$$P(T^{+} \\mid H^{-}) = \\frac{P(T^{+} \\cap H^{-})}{P(H^{-})}$$\nWe have already determined the denominator, $P(H^{-}) = 0.98$. Now we must find the numerator, $P(T^{+} \\cap H^{-})$, which is the probability of a positive test result occurring in a person who is not infected with *E. histolytica*.\n\nWe can express the joint event $T^{+} \\cap H^{-}$ using the composition of $H^{-}$:\n$$T^{+} \\cap H^{-} = T^{+} \\cap (D \\cup C \\cup N)$$\nBy the distributive property of set intersection over union, this becomes:\n$$T^{+} \\cap H^{-} = (T^{+} \\cap D) \\cup (T^{+} \\cap C) \\cup (T^{+} \\cap N)$$\nSince the events $D$, $C$, and $N$ are mutually exclusive, the joint events $(T^{+} \\cap D)$, $(T^{+} \\cap C)$, and $(T^{+} \\cap N)$ are also mutually exclusive. Therefore, the probability of their union is the sum of their individual probabilities:\n$$P(T^{+} \\cap H^{-}) = P(T^{+} \\cap D) + P(T^{+} \\cap C) + P(T^{+} \\cap N)$$\nThis step is an application of the Law of Total Probability to the event $T^{+}$ over the partition $\\{D, C, N\\}$ of the event space $H^{-}$.\n\nEach term in the sum can be re-written using the definition of conditional probability, $P(A \\cap B) = P(A \\mid B)P(B)$:\n$P(T^{+} \\cap D) = P(T^{+} \\mid D) P(D)$\n$P(T^{+} \\cap C) = P(T^{+} \\mid C) P(C)$\n$P(T^{+} \\cap N) = P(T^{+} \\mid N) P(N)$\n\nThe problem provides the necessary values:\n$P(T^{+} \\mid D) = 0.85$\n$P(T^{+} \\mid C) = 0.07$\n$P(T^{+} \\mid N) = 0.01$\n$P(D) = 0.25$\n$P(C) = 0.12$\n$P(N) = 0.61$\n\nSubstituting these values, we calculate each term:\n$P(T^{+} \\cap D) = 0.85 \\times 0.25 = 0.2125$\n$P(T^{+} \\cap C) = 0.07 \\times 0.12 = 0.0084$\n$P(T^{+} \\cap N) = 0.01 \\times 0.61 = 0.0061$\n\nNow, we sum these probabilities to find $P(T^{+} \\cap H^{-})$:\n$$P(T^{+} \\cap H^{-}) = 0.2125 + 0.0084 + 0.0061 = 0.2270$$\n\nFinally, we can compute the false positive rate $P(T^{+} \\mid H^{-})$:\n$$P(T^{+} \\mid H^{-}) = \\frac{P(T^{+} \\cap H^{-})}{P(H^{-})} = \\frac{0.2270}{0.98}$$\nEvaluating this numerically:\n$$P(T^{+} \\mid H^{-}) \\approx 0.23163265...$$\nThe problem requires the result to be rounded to four significant figures.\n$$P(T^{+} \\mid H^{-}) \\approx 0.2316$$", "answer": "$$\\boxed{0.2316}$$", "id": "4803304"}, {"introduction": "The ultimate goal of a diagnostic test is to provide clinically meaningful information. This final practice bridges the gap between a laboratory result and its real-world predictive power by introducing the concept of Positive Predictive Value ($PPV$) [@problem_id:4803305]. Using Bayes' theorem, you will calculate the probability that a patient with a positive microscopy result actually has the disease, learning how test sensitivity ($Se$), specificity ($Sp$), and disease prevalence ($p$) combine to determine the true meaning of a positive finding.", "problem": "A public health laboratory in an endemic region evaluates a stool light microscopy protocol that reports a specimen as “positive for the Entamoeba histolytica/Entamoeba dispar complex” when morphologic features consistent with the complex are seen. Because light microscopy cannot distinguish Entamoeba histolytica from the non-pathogenic lookalikes Entamoeba dispar and Entamoeba coli, the laboratory validates performance against a nucleic acid amplification reference test based on polymerase chain reaction (PCR). Let the true infection status with Entamoeba histolytica be denoted by the event $D^{+}$ and its absence by $D^{-}$. The microscopy result is $T^{+}$ if the complex is reported and $T^{-}$ otherwise. By validation, the microscopy has sensitivity $Se = P(T^{+}\\mid D^{+})$ and specificity $Sp = P(T^{-}\\mid D^{-})$, and the true prevalence of Entamoeba histolytica among tested patients is $p = P(D^{+})$.\n\nUsing only the definitions of sensitivity, specificity, prevalence, the law of total probability, and Bayes’ theorem, derive an expression for the positive predictive value $PPV = P(D^{+}\\mid T^{+})$ in terms of $Se$, $Sp$, and $p$. Then evaluate this expression for $p = 0.03$, $Se = 0.78$, and $Sp = 0.91$. Express the final $PPV$ as a decimal and round your answer to four significant figures. Do not use a percentage sign.", "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n### Step 1: Extract Givens\n- Event $D^{+}$: True infection with *Entamoeba histolytica*.\n- Event $D^{-}$: Absence of true infection with *Entamoeba histolytica*.\n- Event $T^{+}$: Microscopy test result is positive.\n- Event $T^{-}$: Microscopy test result is negative.\n- Sensitivity: $Se = P(T^{+}\\mid D^{+})$.\n- Specificity: $Sp = P(T^{-}\\mid D^{-})$.\n- Prevalence: $p = P(D^{+})$.\n- Positive Predictive Value (to be derived): $PPV = P(D^{+}\\mid T^{+})$.\n- The derivation must use only the definitions of sensitivity, specificity, prevalence, the law of total probability, and Bayes’ theorem.\n- The derived expression is to be evaluated for the specific values: $p = 0.03$, $Se = 0.78$, and $Sp = 0.91$.\n- The final numerical answer for the $PPV$ must be a decimal rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem is a standard and realistic application of Bayesian probability to the evaluation of a medical diagnostic test. The context, involving the differential diagnosis of *Entamoeba histolytica* from its non-pathogenic mimics (*E. dispar*, *E. coli*) using microscopy versus a PCR standard, is a classic and factually correct scenario in clinical microbiology and public health. The provided numerical values for prevalence, sensitivity, and specificity are plausible for this diagnostic context.\n- **Well-Posed:** The problem is well-posed. It clearly defines all variables and events, states the required derivation, provides the necessary numerical values for calculation, and specifies the format of the final answer. A unique solution exists and can be obtained by standard application of probability theory.\n- **Objective:** The problem is stated in objective, formal language, free of ambiguity or subjective claims.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is scientifically sound, well-posed, and objective. A full solution will be provided.\n\n### Derivation of the Positive Predictive Value ($PPV$)\n\nThe Positive Predictive Value ($PPV$) is the probability that a subject has the disease, given that they have a positive test result. This is expressed as the conditional probability $P(D^{+}\\mid T^{+})$.\n\nAccording to the definition of conditional probability, which is the foundation of Bayes' theorem, we have:\n$$PPV = P(D^{+}\\mid T^{+}) = \\frac{P(D^{+} \\cap T^{+})}{P(T^{+})}$$\n\nThe numerator, $P(D^{+} \\cap T^{+})$, represents the joint probability of having the disease and testing positive (a true positive). This can be re-expressed using the definition of sensitivity, $Se = P(T^{+}\\mid D^{+}) = \\frac{P(D^{+} \\cap T^{+})}{P(D^{+})}$. Rearranging this gives:\n$$P(D^{+} \\cap T^{+}) = P(T^{+}\\mid D^{+}) \\cdot P(D^{+})$$\nUsing the problem's given symbols, this becomes:\n$$P(D^{+} \\cap T^{+}) = Se \\cdot p$$\n\nThe denominator, $P(T^{+})$, is the overall probability of receiving a positive test result. To find this, we use the law of total probability. A positive test can occur in two mutually exclusive ways: a true positive ($D^{+} \\cap T^{+}$) or a false positive ($D^{-} \\cap T^{+}$).\n$$P(T^{+}) = P(D^{+} \\cap T^{+}) + P(D^{-} \\cap T^{+})$$\nUsing the definition of conditional probability for each term:\n$$P(T^{+}) = P(T^{+}\\mid D^{+}) \\cdot P(D^{+}) + P(T^{+}\\mid D^{-}) \\cdot P(D^{-})$$\n\nWe identify the terms using the given definitions:\n1.  $P(T^{+}\\mid D^{+}) = Se$ (Sensitivity)\n2.  $P(D^{+}) = p$ (Prevalence)\n3.  $P(D^{-})$ is the probability of not having the disease, which is $P(D^{-}) = 1 - P(D^{+}) = 1 - p$.\n4.  $P(T^{+}\\mid D^{-})$ is the probability of a positive test given no disease (the false positive rate). We are given the specificity, $Sp = P(T^{-}\\mid D^{-})$. Since a subject with no disease can either test negative or positive, $P(T^{+}\\mid D^{-}) + P(T^{-}\\mid D^{-}) = 1$. Therefore, the false positive rate is $P(T^{+}\\mid D^{-}) = 1 - Sp$.\n\nSubstituting these into the expression for $P(T^{+})$:\n$$P(T^{+}) = (Se \\cdot p) + ((1 - Sp) \\cdot (1 - p))$$\n\nNow, we substitute the expressions for the numerator and the denominator back into the formula for $PPV$:\n$$PPV = \\frac{Se \\cdot p}{(Se \\cdot p) + ((1 - Sp) \\cdot (1 - p))}$$\nThis is the derived expression for the Positive Predictive Value in terms of sensitivity ($Se$), specificity ($Sp$), and prevalence ($p$).\n\n### Numerical Evaluation\n\nWe are asked to evaluate this expression for the given values:\n- $p = 0.03$\n- $Se = 0.78$\n- $Sp = 0.91$\n\nFirst, we calculate the value of the numerator (the probability of a true positive):\n$$\\text{Numerator} = Se \\cdot p = 0.78 \\cdot 0.03 = 0.0234$$\n\nNext, we calculate the value of the denominator. The first term of the denominator is the same as the numerator, $0.0234$. The second term is the probability of a false positive:\n$$(1 - Sp) \\cdot (1 - p) = (1 - 0.91) \\cdot (1 - 0.03) = 0.09 \\cdot 0.97 = 0.0873$$\nThe total probability of a positive test, $P(T^{+})$, is the sum of these two terms:\n$$\\text{Denominator} = P(T^{+}) = 0.0234 + 0.0873 = 0.1107$$\n\nFinally, we calculate the $PPV$:\n$$PPV = \\frac{0.0234}{0.1107} \\approx 0.2113821138...$$\n\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $2$, $1$, $1$, $3$. The fifth significant digit is $8$, which is greater than or equal to $5$, so we round up the fourth significant digit ($3$) to $4$.\n\nTherefore, the final value is $0.2114$.", "answer": "$$\\boxed{0.2114}$$", "id": "4803305"}]}